SterRx recalls NOREPINEPHRINE 4mg per 250mL injection (Rx only) due to lack of sterility assurance. This may cause infections if used improperly. Contact SterRx for details.
Lack of Assurance of Sterility
SterRx is recalling NOREPINEPHRINE 4 mg per 250 mL injection (Rx only) because it lacks sterility assurance. This could lead to infections if the medication is used without proper sterilization.
The injection lacks sterility assurance, meaning it could contain harmful bacteria or other contaminants. If not properly sterilized before use, this could cause infections in patients.
Prescription patients using this specific injection for medical treatment. Those with compromised immune systems may be at higher risk.
Check for the product name 'NOREPINEPHRINE, 4 mg per 250 mL, (18 mcg per mL) in 0.9% Sodium Chloride Injection' with NDC 70324-651-01. It was sold from November 2021 to July 2022.
Look for the NDC code 70324-651-01 on the label to confirm if you have the recalled product.
The recall states there is a lack of sterility assurance, so it is not safe to use as it could cause infections.
The recall record does not specify a remedy or replacement process.
The product was first sold in November 2021 based on the recall dates.
We’ve drafted a message you can send SterRx to request your refund or repair — edit it as you like.
Subject: Recall D-0320-2022 — SterRx SterRx Hello, I own a SterRx that is covered by recall D-0320-2022 from SterRx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
